NCT05293015

Brief Summary

The primary objective of this study is to determine the benefits of interventions from a Multidisciplinary Diabetes Care team involved of diabetes nurse practitioners(DNP) on glucose control, perioperative outcomes and psychosocial outcomes for patients with Diabetes Mellitus

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable diabetes

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 23, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

March 23, 2022

Status Verified

December 1, 2021

Enrollment Period

12 months

First QC Date

December 29, 2021

Last Update Submit

March 14, 2022

Conditions

Keywords

nurse practitioners, Multidisciplinary Diabetes Management, perioperative period

Outcome Measures

Primary Outcomes (1)

  • EFFICACY: TIR(Time in Range)

    Time in range

    From into the group to the first hospital day; First day in hospital to the day of discharge

Secondary Outcomes (9)

  • EFFICACY: Glycated Serum Protein

    baseline and 1 month after discharged

  • EFFICACY: Incidence of perioperative hypoglycemia

    From into the grop to 1 month after surgery. And confirmed based on the patient's main complaint and monitoring records.

  • EFFICACY: Time required for blood glucose standard before surgery

    the first hospital day

  • EFFICACY: Diabetes self-management behavior

    Measurements were taken at baseline, day of hospitalization, and 1 month after discharge

  • EFFICACY: Incidence of perioperative adverse events

    1 month after discharge

  • +4 more secondary outcomes

Study Arms (2)

NP-Supported Multidisciplinary Diabetes Management

EXPERIMENTAL

NP establishes files to evaluate and manage patients before hospital and visits patients after hospitalization. Then set blood glucose control goals with endocrinology and orthopedic doctors together, initiates consultation with endocrinologists for patients with postoperative hyperglycemia, and is responsible for post-hospital follow-up.

Other: NP-Supported Multidisciplinary Diabetes Management

Regular diabetes management

NO INTERVENTION

The patient would go to the endocrinology outpatient clinic before hospitalization to regulate blood glucose, and be managed by by orthopedic medical staff through hospitalization. If necessary, the endocrinologist is consulted. And after the hospital, patients would be followed up by orthopedic medical staff.

Interventions

NP establishes files to evaluate and manage patients before hospital and visits patients after hospitalization. Then set blood glucose control goals with endocrinology and orthopedic doctors together, initiates consultation with endocrinologists for patients with postoperative hyperglycemia, and is responsible for post-hospital follow-up.

NP-Supported Multidisciplinary Diabetes Management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis meets World Health Organization (WHO) (1999) Diabetes Diagnostic Standards
  • Orthopedic assessment requires elective surgery and no surgical contraindications
  • HbA1c≥8.5% or intravenous fasting blood glucose (FBG)\>10mmol/l
  • Informed consent.

You may not qualify if:

  • Cognitive and communication disorders;
  • Pregnancy;
  • Participate in other intervention studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, Chen TL. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care. 2014 Aug;37(8):2246-52. doi: 10.2337/dc13-2957. Epub 2014 May 7.

    PMID: 24804698BACKGROUND
  • Meneghini LF. Perioperative management of diabetes: translating evidence into practice. Cleve Clin J Med. 2009 Nov;76 Suppl 4:S53-9. doi: 10.3949/ccjm.76.s4.09.

    PMID: 19880837BACKGROUND
  • Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004 Feb;27(2):553-91. doi: 10.2337/diacare.27.2.553. No abstract available.

    PMID: 14747243BACKGROUND
  • Sebranek JJ, Lugli AK, Coursin DB. Glycaemic control in the perioperative period. Br J Anaesth. 2013 Dec;111 Suppl 1:i18-34. doi: 10.1093/bja/aet381.

    PMID: 24335396BACKGROUND
  • Aminian A, Kashyap SR, Burguera B, Punchai S, Sharma G, Froylich D, Brethauer SA, Schauer PR. Incidence and Clinical Features of Diabetic Ketoacidosis After Bariatric and Metabolic Surgery. Diabetes Care. 2016 Apr;39(4):e50-3. doi: 10.2337/dc15-2647. Epub 2016 Jan 28. No abstract available.

    PMID: 26822327BACKGROUND
  • Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999 Sep;22(9):1408-14. doi: 10.2337/diacare.22.9.1408.

    PMID: 10480501BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2021

First Posted

March 23, 2022

Study Start

April 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

March 23, 2022

Record last verified: 2021-12